Toggle navigation
Home
Search
Services
Blog
Contact
About
Phaseii Clinical Studies with Lhrh Agonists
Henzl, Milan
Syntex (USA), Inc.-Research Division, Palo Alto, CA, United States
Search grants from Milan Henzl
Search grants from Syntex (USA), Inc.-Research Division
Share this grant:
:
:
Abstract
Funding
Institution
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Administrative Core
Phase 2 Study of RV001 for Treatment of Thyroid Eye Disease
In Vivo Directed Evolution of Adeno-Associated Virus Vectors for Glioblastoma Multiforme Tumor-Initiating Cells
Biology of the Lung: a Multidisciplinary Program
Tuberculosis Elimination and Laboratory
Recently added grants:
Blrd Research Career Scientist Award Application
Strategic Molecular Activations for the Selective Synthesis of 2-Deoxy-Beta-Glycosides, and for the Synthesis of Novel Donor-Acceptor Stenhouse Adducts
A Dental implant registry of treatment outcomes of implant therapy by practitioners in the National Dental Practice Based Research Network
Technology-based intervention for alcohol-related sexual risk behaviors in young women with sexual victimization histories
Melanocortin 3 receptor in neural circuits linking reproductive state and metabolism
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research and Development Contracts (N01)
Project #
N01HD032831-004
Application #
3650645
Study Section
Project Start
1983-09-30
Project End
1985-11-29
Budget Start
1985-09-30
Budget End
1985-09-29
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Syntex (USA), Inc.-Research Division
Department
Type
DUNS #
City
Palo Alto
State
CA
Country
United States
Zip Code
94304
Publications
Monroe, S E; Blumenfeld, Z; Andreyko, J L et al.
(1986)
Dose-dependent inhibition of pituitary-ovarian function during administration of a gonadotropin-releasing hormone agonistic analog (nafarelin).
J Clin Endocrinol Metab 63:1334-41
Comments
Be the first to comment on Milan Henzl's grant